Seroprevalence and Molecular Epidemiology of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 in Blood Donors from Dakar, Senegal-Reference-Cited by-同舟云学术

Seroprevalence and Molecular Epidemiology of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 in Blood Donors from Dakar, Senegal

Published:2006-04 Issue:4 Volume:44 Page:1550-1554
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Diop Saliou¹,Calattini Sara²,Abah-Dakou Julienne¹,Thiam Doudou¹,Diakhaté Lamine¹,Gessain Antoine²

Affiliation:

1. Centre National de Transfusion Sanguine, Ave. Cheikh Anta Diop, Fann, BP 5002 Dakar, Sénégal

2. Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Département Ecosytèmes et Epidémiologie des Maladies Infectieuses, Institut Pasteur, 75015 Paris, France

Abstract

ABSTRACT In 2002, human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 seroprevalence was 0.16% (8/4,900) in blood donors from Dakar, Senegal. Most of the positive donors originated from the country’s southern region. Seven donors were infected by HTLV-1 (of cosmopolitan subtype), and one was infected by HTLV-2. These data highlight the problem of transfusion safety in this area where HTLV-1-associated lymphoproliferative and neurological diseases are endemic.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.44.4.1550-1554.2006

Reference35 articles.

1. Prevalence of Blood-Borne Infectious Diseases in Blood Donors in Ghana

2. Balogou, A. A., E. K. Grunitzky, T. K. Anani, A. Kowu, A. Sadzo-Hetsu, K. A. Nubukpo, and M. Dumas. 2000. Prevalence of HTLV-1 virus infection in Togo (Kozah prefecture and the University Hospital Center of Lome). Bull. Soc. Pathol. Exot.93:3-5.

3. Biggar, R. J., P. L. Gigase, M. Melbye, L. Kestens, P. S. Sarin, A. J. Bodner, P. Demedts, W. J. Stevens, L. Paluku, C. Delacollette, et al. 1985. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancetii:520-523.

4. Biggar, R. J., C. Saxinger, C. Gardiner, W. E. Collins, P. H. Levine, J. W. Clark, F. K. Nkrumah, and W. A. Blattner. 1984. Type-I HTLV antibody in urban and rural Ghana, West Africa. Int. J. Cancer34:215-219.

5. Bonis, J., P. M. Preux, L. Nzisabira, L. Letenneur, G. Muhirwa, T. Buzingo, A. Kamuragiye, C. Preux, E. Ngoga, M. Dumas, et al. 1994. HTLV-I in Burundi (east Africa): lack of reactivity to the HTLV-I immunodominant envelope epitope. J. Acquir. Immune Defic. Syndr.7:1099-1100.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene expression profiling of <i>p53</i> and <i>c-myc</i> in HTLV-1 positive blood donors in Congo;Problems of Virology;2024-05-06

2. Geographic distribution, clinical epidemiology and genetic diversity of the human oncogenic retrovirus HTLV-1 in Africa, the world’s largest endemic area;Frontiers in Immunology;2023-02-03

3. Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection;Clinical Microbiology Reviews;2022-04-20

4. The Epidemiological Impact of STIs among General and Vulnerable Populations of the Amazon Region of Brazil: 30 years of Surveillance;Viruses;2021-05-07

5. HTLV in South America: Origins of a silent ancient human infection;Virus Evolution;2020-07-01